GlobeNewswire Inc | Nov 11, 2021 08:01AM EST

November 11, 2021

NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc.(Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced thatJerry Durso, President and Chief Executive Officer of Intercept; M. Michelle Berrey, M.D., M.P.H., President of Research & Development and Chief Medical Officer of Intercept; Linda Richardson, Chief Commercial Officer of Intercept; and Andrew Saik, Chief Financial Officer of Intercept, will participate virtually in fireside chats at the following upcoming investor conferences:

-- The 2021 Jefferies London Healthcare Conference, for which the pre-recorded chat will be made available on November 18, 2021; -- The Piper Sandler 33rd Annual Virtual Healthcare Conference, for which the pre-recorded chat will be made available on November 22, 2021.

The presentations can be accessedon the investor page of Intercepts website at http://ir.interceptpharma.com, and an audio archive of the pre-recorded chats will also be available on Intercepts website for approximately two weeks from the time they are made available.

About InterceptIntercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 inNew York, Intercept has operations inthe United States,EuropeandCanada. For more information, please visitwww.interceptpharma.comor connect with the company onTwitterandLinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries:investors@interceptpharma.com

Media inquiries:media@interceptpharma.com